邦器生物

邦器生物

邦器生物

Biotech/Healthcare

Founded in 2020, Bangqi Biotechnology develops instruments and reagents for autoimmune and allergy diagnostics. The company has established a comprehensive product portfolio and assembled a full-industry-chain team covering R&D, manufacturing, registration and quality, supply chain, and sales…

Latest round: Series B (2024)

Source: ChinaBulls — chinabulls.com

Last updated 2024-11-01

Funding history

Request access to view this section.

Investors

Request access to view this section.

HQ & website

Request access to view this section.

Tags

Request access to view this section.